Lyell Immunophma CEO Lynn Seely Executes Automatic Stock Sale to Cover Tax Obligations
Lyell Immunopharma, Inc. (NASDAQ: LYEL) President and Chief Executive Officer Lynn Seely sold 388 shares of common stock on May 11, 2026. The automatic transaction, totaling $7,337, was executed to cover tax withholding obligations from the settlement of vested restricted stock units. Following the sale, Ms. Seely retains direct ownership of 73,878…